User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 17:58, 1 May 2009 (diff | hist) . . (+13) . . N Seroxat (New page: See SSRIs) (current)
- 17:57, 1 May 2009 (diff | hist) . . (+16) . . GlaxoSmithKline
- 00:22, 12 March 2009 (diff | hist) . . (+1,456) . . European Medicines Agency (→People) (current)
- 16:18, 9 March 2009 (diff | hist) . . (+34) . . N EMEA (New page: See European Medicines Agency.) (current)
- 16:17, 9 March 2009 (diff | hist) . . (+697) . . N European Medicines Agency (New page: ==Background== The European Medicines Agency (EMEA) is a decentralised body of the European Union with headquarters in London. Its main responsibility is the protection and promot...)
- 16:12, 9 March 2009 (diff | hist) . . (+60) . . N MHRA (New page: See Medicines and Healthcare products Regulatory Agency.) (current)
- 16:12, 9 March 2009 (diff | hist) . . (+14) . . N Selective serotonin reuptake inhibitors (New page: See SSRIs.) (current)
- 16:04, 9 March 2009 (diff | hist) . . (+47) . . m SSRIs (current)
- 16:02, 9 March 2009 (diff | hist) . . (-3,458) . . Offshore - and out of reach to the Revenue (Removing all content from page) (current)
- 15:58, 9 March 2009 (diff | hist) . . (+3,806) . . N Pharma: Tax Avoidance (New page: '''Pharma: Tax Evasion''' A report in '''The Guardian''' shows how pharmaceutical giants GlaxoSmithKline and AstraZeneca "offshore" legal ownership of their valuable trademarks to...)
- 15:46, 9 March 2009 (diff | hist) . . (-2,814) . . When is a drug deemed so 'successful' that it deserves to be pulled off a trial? (Removing all content from page) (current)
- 15:39, 9 March 2009 (diff | hist) . . (+1) . . FDA Approval Process: Political Lobbying (current)
- 15:34, 9 March 2009 (diff | hist) . . (+7,381) . . N FDA Approval Process: Political Lobbying (New page: '''FDA Approval Process: Political Lobbying''' The Food and Drug Administration (FDA) aims to protect the health of the American people. It assures the ‘safety, efficacy, and se...)
- 13:55, 9 March 2009 (diff | hist) . . (+24) . . Food and Drug Administration (→About)
- 13:55, 9 March 2009 (diff | hist) . . (+3) . . Food and Drug Administration (→About)
- 13:54, 9 March 2009 (diff | hist) . . (+709) . . Food and Drug Administration
- 13:38, 9 March 2009 (diff | hist) . . (+37) . . N FDA (New page: See Food and Drug Administration.) (current)
- 18:23, 3 March 2009 (diff | hist) . . (+1,135) . . Medicines and Healthcare products Regulatory Agency (→People)
- 17:59, 3 March 2009 (diff | hist) . . (+882) . . Medicines and Healthcare products Regulatory Agency
- 17:31, 3 March 2009 (diff | hist) . . (+33) . . Meningitis C Vaccine (→Contamination) (current)
- 16:16, 3 March 2009 (diff | hist) . . (+1,415) . . N Meningitis C Vaccine
- 15:42, 3 March 2009 (diff | hist) . . (+436) . . Industry-friendly experts (→In the Pharma field) (current)
- 22:04, 17 February 2009 (diff | hist) . . (+25) . . When is a drug deemed so 'successful' that it deserves to be pulled off a trial?
- 21:44, 17 February 2009 (diff | hist) . . (+24) . . Wyeth
- 21:43, 17 February 2009 (diff | hist) . . (+24) . . Schering-Plough
- 21:43, 17 February 2009 (diff | hist) . . (+24) . . Sanofi-Aventis Group
- 21:42, 17 February 2009 (diff | hist) . . (+24) . . Pfizer
- 21:41, 17 February 2009 (diff | hist) . . (+24) . . Novartis
- 21:41, 17 February 2009 (diff | hist) . . (-14) . . Merck and Co. Inc.
- 21:40, 17 February 2009 (diff | hist) . . (+24) . . Johnson & Johnson
- 21:39, 17 February 2009 (diff | hist) . . (+24) . . Roche
- 21:39, 17 February 2009 (diff | hist) . . (+24) . . Eli Lilly and Company
- 21:37, 17 February 2009 (diff | hist) . . (+24) . . Bristol-Myers Squibb
- 21:36, 17 February 2009 (diff | hist) . . (+24) . . AstraZeneca
- 21:35, 17 February 2009 (diff | hist) . . (+448) . . Vioxx
- 21:29, 17 February 2009 (diff | hist) . . (+24) . . Vioxx
- 21:28, 17 February 2009 (diff | hist) . . (+24) . . SSRIs
- 21:27, 17 February 2009 (diff | hist) . . (+16) . . Gardasil
- 21:26, 17 February 2009 (diff | hist) . . (+24) . . Food and Drug Administration
- 21:24, 17 February 2009 (diff | hist) . . (+25) . . GlaxoSmithKline
- 18:58, 17 February 2009 (diff | hist) . . (+116) . . N Category:Pharma
- 17:42, 12 February 2009 (diff | hist) . . (+1,044) . . N Gardasil
- 17:28, 8 February 2009 (diff | hist) . . (-54) . . Offshore - and out of reach to the Revenue (→Notes)
- 17:26, 8 February 2009 (diff | hist) . . (+79) . . Offshore - and out of reach to the Revenue (→Notes)
- 19:03, 3 February 2009 (diff | hist) . . (+3,433) . . N Offshore - and out of reach to the Revenue
- 18:02, 2 February 2009 (diff | hist) . . (+5,764) . . N MMR
- 15:51, 2 February 2009 (diff | hist) . . (+107) . . Harald zur Hausen (current)
- 13:12, 30 January 2009 (diff | hist) . . (+597) . . N The Gairdner Foundation (current)
- 13:02, 30 January 2009 (diff | hist) . . (+2,240) . . N Harald zur Hausen
- 15:17, 21 January 2009 (diff | hist) . . (-39) . . Adam Jacobs (current)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
